Search

everythinglearnresearchcommunity

for

Search:↓

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Minoxidil solution safely and effectively treats hair loss.

Home-use microneedle devices might safely boost 5% minoxidil's effectiveness for hair growth.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Aging significantly affects the hair and scalp of nonbalding Caucasian women, with changes that differ from male pattern baldness.

PLD is an effective and safer alternative for treating breast cancer.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Improved Finasteride delivery for hair loss treatment.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Tattooing guidelines focus on safety, hygiene, and following rules.

Some dermatology patients in Turkey use traditional medicine, with herbal remedies being most common, but these treatments can have mixed results and risks.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Most patients stop using topical minoxidil due to side effects.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Higher doses of isotretinoin may lead to more hair loss.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.